The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man
Open accessAbstract
BACKGROUND AND METHODS: Mutations in the estrogen-receptor gene have been thought to be lethal. A 28-year-old man whose estrogen resistance was caused by a disruptive mutation in the estrogen-receptor gene underwent studies of pituitary-gonadal function and bone density and received transdermal estrogen for six months. Estrogen-receptor DNA, extracted from lymphocytes, was evaluated by analysis of single-strand-conformation polymorphisms and by direct sequencing. RESULTS: The patient was tall (204 cm [80.3 in.]) and had incomplete epiphyseal closure, with a history of continued linear growth into adulthood despite otherwise normal pubertal development. He was normally masculinized and had bilateral axillary acanthosis nigricans. Serum estradiol and estrone concentrations were elevated, and serum testosterone concentrations were normal. Serum follicle-stimulating hormone and luteinizing hormone concentrations were increased. Glucose tolerance was impaired, and hyperinsulinemia was present. The bone mineral density of the lumbar spine was 0.745 g per square centimeter, 3.1 SD below the mean for age-matched normal women; there was biochemical evidence of increased bone turnover. The patient had no detectable response to estrogen administration, despite a 10-fold increase in the serum free estradiol concentration. Conformation analysis of his estrogen-receptor gene revealed a variant banding pattern in exon 2. Direct sequencing of exon 2 revealed a cytosine-to-thymine transition at codon 157 of both alleles, resulting in a premature stop codon. The patient's parents were heterozygous carriers of this mutation, and pedigree analysis revealed consanguinity. CONCLUSIONS: Disruption of the estrogen receptor in humans need not be lethal. Estrogen is important for bone maturation and mineralization in men as well as women.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One patient had a BMI in the obese range of 30 kg/m2 and clinical evidence of insulin resistance, 196 although fat mass was not reported.”
From The role of the androgen receptor in the pathogenesis of obesity and its utility as a target for obesity treatments (2022) · cites this paper as [196]
Citations
Cites
RADIOGRAPHIC ATLAS OF SKELETAL DEVELOPMENT OF THE HAND AND WRIST
GREULICH, W. W., & Pyle, S. I. (1959) · The American Journal of the Medical Sciences · doi:10.1097/00000441-195909000-00030 · Cited by 5,562
Orita, M., Suzuki, Y., Sekiya, T., & Hayashi, K. (1989) · Genomics · doi:10.1016/0888-7543(89)90129-8 · Cited by 3,419
Lubahn, D. B., Moyer, J. S., GOLDING, T. S., Couse, J. F., Korach, K. S., & Smithies, O. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11162 · Cited by 1,902
Self-citationHanson, D. A., Weis, M. A., Bollen, A., Maslan, S., Singer, F. R., & Eyre, D. W. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650071119 · Cited by 653
Genomic organization of the human oestrogen receptor gene.
Ponglikitmongkol, M., Green, S., & Chambon, P. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03211.x · Cited by 485
Osteopenia in Men with a History of Delayed Puberty
Finkelstein, J. S., Neer, R. M., Biller, B. M. K., Crawford, J. D., & Klibanski, A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202273260904 · Cited by 436
Osteoporosis in Men with Idiopathic Hypogonadotropic Hypogonadism
Finkelstein, J. S., KLIBANSKI, A., NEER, R. M., GREENSPAN, S. L., ROSENTHAL, D. I., & CROWLEY, W. F. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-3- · Cited by 407
Conte, F. A., Grumbach, M. M., Ito, Y., Fisher, C. R., & Simpson, E. R. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.6.8200927 · Cited by 379
Vitamin-D-Dependent Rickets Type II
Brooks, M. H., Bell, N. H., Love, L., Stern, P. H., Orfei, E., Queener, S. F., Hamstra, A. J., & DeLuca, H. F. (1978) · New England Journal of Medicine · doi:10.1056/nejm197805042981804 · Cited by 346
Origin of Estrogen in Normal Men and in Women with Testicular Feminization*
MacDonald, P. C., Madden, J. D., Brenner, P. F., Wilson, J. D., & Siiteri, P. K. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-49-6-905 · Cited by 318
Research works printed but not linked: 3
- Valenta LJ, 1992, J Natl Med Assoc, 84, 241
- Swartz CM, 1988, N Engl J Med, 318, 996
- Sharp SC, 1993, Diabetes Rev, 1, 318
Cited by
Sorted by citations
Items 801–900 of 1,010
Unresolved Issues in Osteoporosis in Men
Seeman, E. (2001) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1010054924085 · Cited by 54
Uebelhart, B., Herrmann, F. R., Pavo, I. J., Draper, M. W., & Rizzoli, R. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040503 · Cited by 54
Hormones and Bone Health in Postmenopausal Women
Lindsay, R. (2004) · Endocrine · doi:10.1385/endo:24:3:223 · Cited by 54
Carel, J. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.04.034 · Cited by 54
Impaired Acetylcholine-Induced Release of Nitric Oxide in the Aorta of Male Aromatase-Knockout Mice
Kimura, M., Sudhir, K., Jones, M. E. E., Simpson, E. R., Jefferis, A., & Chin-Dusting, J. P. F. (2003) · Circulation Research · doi:10.1161/01.res.0000103172.98986.25 · Cited by 54
Maghnie, M., Ambrosini, L., Cappa, M., Pozzobon, G. C., Ghizzoni, L., Ubertini, M. G., Iorgi, N. D., Tinelli, C., Pilia, S., Chiumello, G., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0050 · Cited by 54
Cheng, M. Z., Zaman, G., Rawlinson, S. C. F., Pitsillides, A. A., Suswillo, R. F. L., & Lanyon, L. E. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.9.1424 · Cited by 54
The Growth and Age-Related Origins of Bone Fragility in Men
Seeman, E. (2004) · Calcified Tissue International · doi:10.1007/s00223-004-0289-4 · Cited by 54
Majdoubi, M. E., Ramaswamy, S., Sahu, A., & Plant, T. M. (2000) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2000.00433.x · Cited by 54
Inhibition of bone resorption by 17β-estradiol in human bone marrow cultures
Sarma, U., Edwards, M. W., Motoyoshi, K., & Flanagan, A. M. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199804)175:1 · Cited by 54
Wang, C. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.4.1462 · Cited by 54
Insulin-like growth factors and skeletal growth: possibilities for therapeutic interventions
Van Wyk, J. J., & Smith, E. P. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.12.6201 · Cited by 53
Self-citationNuclear receptor superfamily: Principles of signaling
Germain, P., Altucci, L., Bourguet, W., Rochette-Egly, C., & Gronemeyer, H. (2003) · Pure and Applied Chemistry · doi:10.1351/pac200375111619 · Cited by 53
Endocrinal metabolic regulation on the skeletal system in post-menopausal women
Thapa, S., Nandy, A., & Rendina-Ruedy, E. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1052429 · Cited by 53
Stopforth, A., Burger, B. V., Crouch, A. M., & Sandra, P. J. F. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2007.05.025 · Cited by 53
Impact of occupational cadmium exposure on bone in sewage workers
Taha, M. M., Mahdy-Abdallah, H., Shahy, E. M., Ibrahim, K. S., & Elserougy, S. (2018) · International Journal of Occupational and Environmental Health · doi:10.1080/10773525.2018.1518745 · Cited by 53
Osteoporosis and Bone Health in Transgender Persons
Stevenson, M. O., & Tangpricha, V. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.02.006 · Cited by 53
Xu, Y., Lin, J., Wang, S., Xiong, J., & Zhu, Q. (2014) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2014.03.002 · Cited by 53
Douchi, T., Oki, T., Yamasaki, H., Kuwahata, R., Nakae, M., & Nagata, Y. (2001) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(01)01450-8 · Cited by 53
Minireview: Regulation of Gene Expression by Nuclear Hormone Receptors
Meier, C. A. (1997) · Journal of Receptors and Signal Transduction · doi:10.3109/10799899709036612 · Cited by 53
Teplyuk, N. M., Zhang, Y., Lou, Y., Hawse, J. R., Hassan, M. Q., Teplyuk, V. I., Pratap, J., Galindo, M., Stein, J. L., Stein, G. S., et al. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0270 · Cited by 52
Expression of estrogen receptor α and β in the epiphyseal plate of the rat
Van der Eerden, B. C. J., Gevers, E. F., Löwik, C. W. G. M., Karperien, M., & Wit, J. M. (2002) · Bone · doi:10.1016/s8756-3282(01)00703-7 · Cited by 52
Molecular Determinants of Pituitary Cytodifferentiation
Asa, S. L., & Ezzat, S. (1999) · Pituitary · doi:10.1023/a:1009948813587 · Cited by 52
Chen, Z., Wang, O., Nie, M., Elison, K., Zhou, D., Li, M., Jiang, Y., Xia, W., Meng, X., Chen, S., et al. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.09.016 · Cited by 52
Vico, L., & Vanacker, J.-M. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0963-5 · Cited by 52
Susceptibility to Early Atherosclerosis in Male Mice Is Mediated by Estrogen Receptor α
Villablanca, A. C., Lubahn, D. B., Shelby, L., Lloyd, K. C. K., & Barthold, S. W. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000130467.65290.d4 · Cited by 52
Self-citationKennedy, J., Baris, C., Hoyland, J. A., Selby, P. L., Freemont, A. J., & Braidman, I. P. (1999) · Bone · doi:10.1016/s8756-3282(98)00148-3 · Cited by 52
Matsumoto, A. M., Tenover, J. L., McClung, M. R., Mobley, D. F., Geller, J., Sullivan, M. J., Grayhack, J. T., Wessells, H., Kadmon, D., Flanagan, M. J., et al. (2002) · The Journal of Urology · doi:10.1097/00005392-200205000-00038 · Cited by 52
Hung, J., Cheng, T.-J. R., Chang, M. D., Chen, K.-D., Huang, H.-L., & Lai, Y. (1998) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19981001)71:1 · Cited by 38
Goetz, T. G., Mamillapalli, R., Devlin, M. J., Robbins, A. E., Zolbin, M. M., & Taylor, H. S. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00161.2017 · Cited by 51
Managing Complications of Androgen Deprivation Therapy for Prostate Cancer
Holzbeierlein, J. M. (2006) · Urologic Clinics of North America · doi:10.1016/j.ucl.2005.12.008 · Cited by 51
Khristi, V., Ratri, A., Ghosh, S., Pathak, D., Borosha, S., Dai, E., Roy, R., Chakravarthi, V. P., Wolfe, M. W., & Rumi, M. A. K. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.04.005 · Cited by 51
Hiroi, H., Momoeda, M., Inoue, S., Tsuchiya, F., Matsumi, H., Tsutsumi, O., Muramatsu, M., & Taketani, Y. (1999) · Endocrine Journal · doi:10.1507/endocrj.46.153 · Cited by 51
Tall Stature without Growth Hormone: Four Male Patients with Aromatase Deficiency
Rochira, V., Zirilli, L., MAFFEI, L. E., Premrou, V., Aranda, C., Baldi, M., Ghigo, E., Aimaretti, G., Carani, C., & Lanfranco, F. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1743 · Cited by 51
Non-neoplastic diseases of the testis
Nistal, M., & Paniagua, R. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-01970-5.50014-2 · Cited by 51
Local IGF-I expression and bone formation
McCarthy, T. L. (2001) · Growth Hormone & IGF Research · doi:10.1054/ghir.2001.0236 · Cited by 51
Phillips, G. B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2011 · Cited by 51
Background for studies on the treatment of male osteoporosis: state of the art
Kaufman, J., Johnell, O., Abadie, E., Adami, S., Audran, M., Avouac, B., Sedrine, W. B., Calvo, G., Devogelaer, J. P., Fuchs, V., et al. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.10.765 · Cited by 51
Men, bone and estrogen: unresolved issues
ORWOLL, E. S. (2003) · Osteoporosis International · doi:10.1007/s00198-002-1332-9 · Cited by 51
Arisaka, O., Hoshi, M., Kanazawa, S., Numata, M., Nakajima, D., Kanno, S., Negishi, M., Nishikura, K., Nitta, A., Imataka, M., et al. (2001) · Metabolism · doi:10.1053/meta.2001.21678 · Cited by 50
Majdič, G., & Tobet, S. A. (2011) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2011.02.009 · Cited by 50
Tissue-specific expression of human ERα and ERβ in the male
Denger, S., Reid, G., Brand, H., Koš, M., & Gannon, F. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00417-8 · Cited by 50
The male climacterium: Clinical signs and symptoms of a changing endocrine environment
van den Beld, A. W., & Lamberts, S. W. J. (2000) · The Prostate · doi:10.1002/1097-0045(2000)45:10+ · Cited by 21
Lorentzon, M., Lorentzon, R., & Nordström, P. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.10.1944 · Cited by 50
Pino, A. M., Rodríguez, J. M., Ríos, S., Astudillo, P., Leiva, L., Seitz, G., Fernández, M., & Rodríguez, J. P. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.07026 · Cited by 50
Cross-sectional study of bone turnover during bicalutamide monotherapy for prostate cancer
Smith, M. R., Fallon, M. A., & Goode, M. (2003) · Urology · doi:10.1016/s0090-4295(02)02006-x · Cited by 50
Spady, T. J., Harvell, D. M. E., Snyder, M. C., Pennington, K. L., McComb, R. D., & Shull, J. D. (1998) · Cancer Letters · doi:10.1016/s0304-3835(97)00455-2 · Cited by 50
Suarez, F., Rossignol, C., & Garabédian, M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.10.5199 · Cited by 50
Wickman, S., & Dunkel, L. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7927 · Cited by 50
Progesterone receptor variants found in breast cells repress transcription by wild-type receptors
Richer, J. K., Lange, C. A., Wierman, A., Brooks, K. M., Tung, L. W., Takimoto, G. S., & Horwitz, K. B. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1005941117247 · Cited by 50
Changes in calcium kinetics associated with menarche
Abrams, S. A., O'Brien, K. O., & Stuff, J. E. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.6.8964820 · Cited by 50
Estrogens: Two nuclear receptors, multiple possibilities
Biason-Lauber, A., & Lang-Muritano, M. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111710 · Cited by 49
Diverse actions of estradiol on anorexigenic and orexigenic hypothalamic arcuate neurons
Stincic, T. L., Rønnekleiv, O. K., & Kelly, M. J. (2018) · Hormones and Behavior · doi:10.1016/j.yhbeh.2018.04.001 · Cited by 49
Walallawita, U. S., Wolber, F. M., Ziv‐Gal, A., Kruger, M. C., & Heyes, J. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197119 · Cited by 49
Estrogens Regulate the Hepatic Effects of Growth Hormone, a Hormonal Interplay with Multiple Fates
Fernández‐Pérez, L., Guerra, B., Díaz-Chico, J. C., & Flores‐Morales, A. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00066 · Cited by 49
Genetic Determinants of Arterial Calcification Associated With Atherosclerosis
Doherty, T. M., Fitzpatrick, L. A., Shaheen, A., Rajavashisth, T. B., & Detrano, R. (2004) · Mayo Clinic Proceedings · doi:10.4065/79.2.197 · Cited by 49
SEMINAL PLASMA MELATONIN AND GONADAL STEROIDS CONCENTRATIONS IN NORMAL MEN
Luboshitzky, R., Shen‐Orr, Z., & Herer, P. (2002) · Archives of Andrology · doi:10.1080/01485010252869324 · Cited by 49
Walvoord, E. C., & Pescovitz, O. H. (1999) · PEDIATRICS · doi:10.1542/peds.104.s5.1010 · Cited by 49
NEW IDEAS FOR MEDICAL TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA
Merke, D. P., & Cutler, G. B. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(08)70022-7 · Cited by 49
Anti-oestrogenic prevention of breast cancer — the make or break point
Powles, T. J. (2002) · Nature reviews. Cancer · doi:10.1038/nrc908 · Cited by 49
Impact of growth plate senescence on catch-up growth and epiphyseal fusion
Nilsson, O., & Baron, J. (2005) · Pediatric Nephrology · doi:10.1007/s00467-004-1689-4 · Cited by 49
Congenital estrogen deficiency: in search of the estrogen role in human male reproduction
Rochira, V., Antonio, B., Madeo, B., Baraldi, E., Faustini‐Fustini, M., Granata, A. R. M., & Carani, C. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00432-4 · Cited by 49
Mechanism of Action and Preclinical Profile of Raloxifene, a Selective Estrogen Receptor Modulator*
Bryant, H. U. (2001) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1010019410881 · Cited by 49
Molecular Basis of Pituitary Development and Cytogenesis
Asa, S. L., & Ezzat, S. (2004) · KARGER eBooks · doi:10.1159/000079035 · Cited by 49
Takayanagi, R., Goto, K., Suzuki, S., Tanaka, S., Shimoda, S., & Nawata, H. (2002) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00394-3 · Cited by 49
Oestrogen receptor mutants and variants in breast cancer
Dowsett, M., Daffada, A. A. I., Chan, C. M. W., & Johnston, S. R. D. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00100-7 · Cited by 49
Szulc, P., Claustrat, B., Munoz, F., Marchand, F., & Delmas, P. D. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02117.x · Cited by 48
Embryonic Development of Bone and Regulation of Intramembranous and Endochondral Bone Formation
Karaplis, A. C. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00025-2 · Cited by 48
The genetic basis of female reproductive disorders: Etiology and clinical testing
Layman, L. C. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.02.016 · Cited by 48
Herrera, A. (2012) · World Journal of Orthopedics · doi:10.5312/wjo.v3.i12.223 · Cited by 48
Late‐onset Hypogonadism: Bone health
Rochira, V. (2020) · Andrology · doi:10.1111/andr.12827 · Cited by 49
Zheng, R., Byberg, L., Larsson, S. C., Höijer, J., Baron, J. A., & Michaëlsson, K. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4298 · Cited by 48
Oestrogen action on bone cells.
Krassas, G. E., & Papadopoulou, P. (2001) · PubMed · Cited by 48
Role of estrogen receptors in the vascular system
Rubanyi, G. M., Kauser, K. Z., & Johns, A. (2002) · Vascular Pharmacology · doi:10.1016/s0306-3623(02)00130-1 · Cited by 48
Díaz-Guerr, G. M., Hawkins, F. G., Rapado, A., Ruiz, M. Á., & Díaz Curiel, M. (2001) · Osteoporosis International · doi:10.1007/s001980170127 · Cited by 48
Osteoporosis: gender differences and similarities
Khosla, S., Melton, L. J., & Riggs, B. L. (1999) · Lupus · doi:10.1177/096120339900800513 · Cited by 48
Steroid Formation in Osteoblast-Like Cells
Saito, H., & Yanaihara, T. (1998) · Journal of International Medical Research · doi:10.1177/030006059802600101 · Cited by 48
Monroe, D., Johnsen, S. A., Subramaniam, M., Getz, B., Khosla, S., Riggs, B. L., & Spelsberg, T. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1760349 · Cited by 48
Optimizing Estrogen Replacement Treatment in Turner Syndrome
Rosenfield, R. L., Perovic, N., Devine, N. A., Mauras, N., Moshang, T., Root, A. W., & Sy, J. P. (1998) · PEDIATRICS · doi:10.1542/peds.102.s3.486 · Cited by 48
Body Composition, Sex Steroids, IGF-1, and Bone Mineral Status in Aging Men
Ravaglia, G., Forti, P., Maioli, F., Nesi, B., Pratelli, L., Cucinotta, D., Bastagli, L., & Cavalli, G. (2000) · The Journals of Gerontology Series A · doi:10.1093/gerona/55.9.m516 · Cited by 48
Factors affecting prepubertal and pubertal bone age progression
Satoh, M., & Hasegawa, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.967711 · Cited by 47
Aromatase inhibitors for short stature in male children and adolescents
McGrath, N., & O'Grady, M. J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010888.pub2 · Cited by 47
Mammalian sperm quality and aromatase expression
Carreau, S., Delalande, C., & Galeraud-Denis, I. (2009) · Microscopy Research and Technique · doi:10.1002/jemt.20703 · Cited by 47
Oestrogens as apoptosis regulators in mammalian testis: angels or devils?
Correia, S., Cardoso, H. J., Cavaco, J. E. B., & Socorro, S. (2015) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2014.25 · Cited by 47
Estradiol-induced regulation of GLUT4 in 3T3-L1 cells: involvement of ESR1 and AKT activation
Campello, R. S., de Fátima, L. A., Barreto-Andrade, J. N., Lucas, T. F. G., Mori, R. C. T., Porto, C. S., & Machado, U. F. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0041 · Cited by 47
Bone and bone marrow disruption by endocrine‐active substances
Agas, D., Lacava, G., & Sabbieti, M. G. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26837 · Cited by 47
Cancer Treatment-Related Bone Disease
Brown, S. A., & Guise, T. A. (2009) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v19.i1.20 · Cited by 47
Jørgensen, A. S., Jacobsen, P., Christiansen, L., Bury, P. S., Kanstrup, A., Thorpe, S. M., Bain, S., Nærum, L., & Wassermann, K. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00015-9 · Cited by 47
Ribeiro, R. S., & Abucham, J. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0084 · Cited by 47
Ikegami, S., Moriwake, T., Tanaka, H., Inoue, M., Kubo, T., Suzuki, S., Kanzaki, S., & Seino, Y. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01416.x · Cited by 47
Matsumoto, A. M., Tenover, J. L., McClung, M. R., Mobley, D. F., Geller, J., Sullivan, M. J., Grayhack, J. T., Wessells, H., Kadmon, D., Flanagan, M. J., et al. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)65095-1 · Cited by 47
Genetic determinants of susceptibility to osteoporosis
Ralston, S. H. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00033-x · Cited by 47
McDougall, K. E., Perry, M. J., Gibson, R., Colley, S. M., Korach, K. S., & Tobias, J. H. (2003) · Endocrinology · doi:10.1210/en.2002-0074 · Cited by 47
Self-citationAndrogens as anabolic agents for bone
ORWOLL, E. S. (1996) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(96)00024-0 · Cited by 47
Estrogen and bone: Insights from estrogen-resistant, aromatase-deficient, and normal men
Khosla, S. (2008) · Bone · doi:10.1016/j.bone.2008.05.005 · Cited by 47
Suba, Z. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s52600 · Cited by 46
Minireview: Neural Signaling of Estradiol in the Hypothalamus
Kelly, M. J., & Rønnekleiv, O. K. (2015) · Molecular Endocrinology · doi:10.1210/me.2014-1397 · Cited by 46
Jee, Y. H., & Baron, J. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.02.068 · Cited by 46
Chapter 18, The Spectrum of Pediatric Osteoporosis
Bianchi, M. L., & Glorieux, F. H. (2011) · Cited by 46
Clinical Laboratory Evaluation of Male Subfertility
Weber, R. F. A., Dohle, G. R., & Romijn, J. C. (2005) · Advances in clinical chemistry · doi:10.1016/s0065-2423(05)40008-6 · Cited by 46
Metadata
- Authors
- Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., Lubahn, D. B., & Korach, K. S.
- Affiliations
- Cincinnati Children's Hospital Medical Center (US)
- National Institutes of Health (US)
- University of North Carolina at Chapel Hill (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1994-10-20
- Volume
- 331
- Issue
- 16
- Pages
- 1056-1061
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2321613759
- Cited by
- 2,471
- References
- 30
- Citations by year
- 2026: 18 · 2025: 26 · 2024: 22 · 2023: 32 · 2022: 36 · 2021: 42 · 2020: 49 · 2019: 55 · 2018: 59 · 2017: 60 · 2016: 60 · 2015: 70 · 2014: 76 · 2013: 72 · 2012: 67
- FWCI
- 35.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Center for Research Resources (M01RR008084, MO1 RR 08084)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Keywords
- estrogen resistance, estrogen receptor gene, estrogen receptor mutations, premature stop codon, pituitary-gonadal function, hyperinsulinemia, impaired glucose tolerance, bone mineral density, bone turnover, epiphyseal closure, consanguinity, transdermal estrogen, tall stature
- MeSH terms
- Adult, Base Sequence, Codon, Drug Resistance, Estrogens, Humans, Male, Molecular Sequence Data, Mutation, Osteoporosis, Pedigree, Receptors, Estrogen, Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review